Today’s Globe

Published October 15, 2010

Today’s Globe
Genzyme Corp., which spurned Sanofi Aventis SAs $ 18.5 billion takeover bid, has been sued by investors who contend the biotechnology company is wrongfully depriving shareholders of the chance to profit from the offer. The Supreme Court heard arguments yesterday…
Read more on Boston Globe

Titan’s Implanted Addiction-Drug Device Works Better Than Placebo in Study
Titan Pharmaceuticals Inc. ’s implanted drug-delivery device helped people fight addiction to heroin and prescription painkillers better than a placebo, a company-funded study found.
Read more on Bloomberg